Abstract
Tacrolimus is known as the most effective immunosuppressive drug which is synthesized by actinobacteria of the genus Streptomyces. Its biosynthesis is accompanied by the formation of the structural analogs. A new method for the production of tacrolimus by Streptomyces tsukubensis BKM Ac-2618D with the use of brominated styrene-divinylbenzene sorbent SP-207 was developed. This approach enabled to increase the yield, prevent undesirable destruction, and simplify the tacrolimus isolation procedure from the cultivation media. The preliminary separation step was optimized by means of the usage of regenerable sorbents such as methylmethacrylate (HP2MG) and chemically modified silica gel (Diasorb-100-Diol). By implementation of the silica gel-based cation exchange resins pretreated with silver ions for the final purification stage, it was possible to increase its productivity. The overall yield of tacrolimus by this method was found to around 60–70%. The results could be implemented for the full-cycle production development of the pharmaceutical grade tacrolimus.
Similar content being viewed by others
REFERENCES
Trede, N.S., Warwick, A.B., Rosoff, P.M., Rohrer, R., Bierer, B.E., and Guinan, E., Bone Marrow Transplant., 1997, vol. 20, no. 3, pp. 257–260.
Meier-Kriesche, LiS., Gruessner, R., Fung, J., Bustami, R., Barr, M., and Leichtman, A., Am. J. Transplant., 2006, vol. 6, no. 5, pp. 1111–1131.
McCormack, P.L. and Keating, G.M., Drugs, 2006, vol. 66, no. 17, pp. 2269–2279.
Akimoto, K., Kusunoki, Y., Nishio, S., Takagi, K., and Kawai, S., Clin. Rheumatol., 2008, vol. 27, no. 11, pp. 1393–1397.
Benson, A., Barrett, T., Sparberg, M., and Buchman, A.L., Inflamm. Bowel Dis., 2008, vol. 14, no. 1, pp. 7–12.
Remitz, A. and Reitamo, S., Expert Opin. Drug Saf., 2009, vol. 8, no. 4, pp. 501–506.
Ingram, J.R., Martin, J.A., and Finlay, A.Y., Am. J. Clin. Dermatol., 2009, vol. 10, no. 4, pp. 229–237.
Barot, R.K., Shitole, S.C., Bhagat, N., Patil, D., Sawant, P., and Patil, K., J. Clin. Diagn. Res., 2016, vol. 10, no. 6, pp. 5–9.
Reis, S.A., Moussatche, N., and Damaso, C.R.A., J. Appl. Microbiol., 2006, vol. 100, no. 6, pp. 1373–1380.
Karpas, A., Lowdell, M., Jacobson, S.K., and Hill, F., Proc. Natl. Acad. Sci. U. S. A., 1992, vol. 89, no. 17, pp. 8351–8355.
Klettner, A. and Herdegen, T., Curr. Drug Targets CNS Neurol. Disord., 2003, vol. 2, no. 3, pp. 153–162.
Konofaos, P. and Terzis, J.K., J. Reconstr. Microsurg., 2013, vol. 29, no. 3, pp. 141–148.
Periyasamy, S., Warrier, M., Tillekeratne, M.P.M., Shou, W., and Sanchez, E.R., Endocrinology, 2007, vol. 148, no. 10, pp. 4716–4726.
Goranovic, D., Blazic, M., Magdevska, V., Horvat, J., Kuscer, E., Polak, T., Santos-Aberturas, J., Martinez-Castro, M., Barreiro, C., and Mrak, P., BMC Microbiol., 2012, vol. 12, no. 1, pp. 238–243.
Barreiro, C. and Martinez-Castro, M., Appl. Microbial. Biotechnol., 2014, vol. 98, no. 2, pp. 497–507.
Jung, S., Lee, K., Park, Y-J., Yoon, S., and Yoo, J., Biotechnol. Bioprocess. Eng, 2011, vol. 16, no. 6, pp. 1208–1213.
Hosoda, J., J. Pharm. Biomed. Anal., 1996, vol. 14, no. 3, pp. 339–346.
The United States Pharmacopeial Convention, USP 37 - NF 32, The United States Pharmacopeia and National Formulary 2014: Main Edition Plus Supplements 1 and 2, 2013.
Int. Patent no. 2006/069386 A1, 2005.
Int. Patent no. 2006/031664 A1, 2005.
Int. Patent no. 2006/048145 A1, 2006.
Int. Patent no. 2005/098011 A1, 2005.
Int. Patent no. 2000/71546 A1, 2000.
Int. Patent no. 2007/017029 A1, 2007.
Int. Patent no. 2009/116729 A2, 2009.
Int. Patent no. 2007/013017 A1, 2007.
Int. Patent no. 2007/106587 A2, 2005.
US Patent no. 0000834 A1, 2008.
Poshekhontseva, V.Y., Bragin, E.Y., Fokina, V.V., Shtratnikova, V.Y., Starodumova, I.P., Tarlachkov, S.V., and Donova, M.V., Microbiol. Resour. Announc., 2019, vol. 8, no. 24. e00510-19.
RF Patent no. 2495937, 2013.
Poshekhontseva, V.Yu., Fokina, V.V., Sukhodol’skaya, G.V., Shutov, A.A., and Donova, M.V., Biotekhnoogiya, 2019, vol. 35, no. 5, pp. 42–50.
Funding
This work was financially supported by the state assignment (project no. AAAA-A16-116062110077-6).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Salionov, D.S., Poshekhontseva, V.Y., Fokina, V.V. et al. Biosynthesis of Tacrolimus by the Streptomyces tsukubensis VKM Ac-2618D Strain in the Presence of Polymeric Sorbents and Development of a Method for Its Isolation and Purification. Appl Biochem Microbiol 56, 699–707 (2020). https://doi.org/10.1134/S0003683820060150
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0003683820060150